Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

Tapentadol in cancer pain management: a prospective open-label study

(2012) Sebastiano Mercadante et al.   CURRENT MEDICAL RESEARCH AND OPINION

Switching From Methadone to Tapentadol for Cancer Pain

(2012) Sebastiano Mercadante et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC

(2012) Augusto Caraceni et al.   LANCET ONCOLOGY

Prospects and challenges in opioid analgesia for pain management

(2011) Sebastiano Mercadante   CURRENT MEDICAL RESEARCH AND OPINION

Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review

(2011) Sebastiano Mercadante et al.   PALLIATIVE MEDICINE

European Palliative Care Research Collaborative pain guidelines: Opioid switching to improve analgesia or reduce side effects. A systematic review

(2011) Ola Dale et al.   PALLIATIVE MEDICINE

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

(2010) Marc Afilalo et al.   CLINICAL DRUG INVESTIGATION

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

(2010) Sherwyn Schwartz et al.   CURRENT MEDICAL RESEARCH AND OPINION

Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?

(2010) Hans G. Kress   EUROPEAN JOURNAL OF PAIN

Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain

(2010) Wolfgang Schröder et al.   EUROPEAN JOURNAL OF PAIN

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

(2010) Robert Buynak et al.   EXPERT OPINION ON PHARMACOTHERAPY

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

(2010) James E. Wild et al.   Pain Practice

Frequency, Indications, Outcomes, and Predictive Factors of Opioid Switching in an Acute Palliative Care Unit

(2009) Sebastiano Mercadante et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain

(2009) Thomas Christoph et al.   NEUROSCIENCE LETTERS